Peptide record

TPDB14620

ACE inhibitors Antibacterial Antifungal Antihypertensive Antiviral Bitter Hemolysis Toxicity Umami standard
2 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB14620
ACE inhibitors Antibacterial Antifungal Antihypertensive Antiviral Bitter Hemolysis Toxicity Umami
Anti-infective peptides Cardiometabolic peptides Toxicity and safety peptides Food sensory peptides
Peptipedia dbAMP DRAMP CAFPdb AHTPDB dbAMP 3.0 Tastepeptides-Meta PD_Hemolysis
standard
No
A 2-aa standard natural multi-activity (ACE inhibitors, Antibacterial, Antifungal, and other sources) peptide sequence curated from Peptipedia, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
LE
Physicochemical Analysis
C11H20N2O5
ARNDCQGHIKMFPSTWYV
EL
260.29
3.29
0
1
1
-1
1.46
0.150
195.00
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
0
0.00
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
1
E
0
Q
0
G
0
H
0
I
1
L
0
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 0 H: 0 I: 0 L: 1 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
2
C11H20N2O5
260.29
3.29
-1
1.46
0.150
Evidence Records 2 records
Evidence 1 Activity

Activity

50% Hemolysis
Toxicity
>>100 µM
Hemolytic Cytotoxic
50% Hemolysis | >>100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Small lipopeptides possess anti-biofilm capability comparable to daptomycin and vancomycin. | RSC Adv | 2015
Evidence 2 Hemolysis

Source & Reference

PD_Hemolysis
PD_Hemolysis